Methylprednisolone attenuates airway and vascular responses induced by reactive oxygen species in isolated, plasma-perfused rat lungs.
The effects of methylprednisolone (MP) on the acute airway and pulmonary vascular responses induced by reactive oxygen species (ROS) were investigated in isolated, plasma-perfused rat lungs. ROS were generated by adding xanthine oxidase and hypoxanthine to the perfusate. MP was administered in 3 different ways: 1. Added to the perfusate (1 mg*ml-1) 5 min prior to xanthine oxidase and hypoxanthine, 2. Given as intraperitoneal injections (40 mg*kg-1) to lung donor rats 12 and 2 hours prior to the experiments, or 3. Combining 1 and 2. The lungs were perfused at constant volume inflow (15 ml*min-1). Pulmonary arterial pressure and transpulmonary pressure were followed for 30 min after addition of xanthine oxidase and hypoxanthine. ROS induced a powerful, acute broncho- and vasoconstriction, which was inhibited by addition of MP to the perfusate. Pretreatment with MP also inhibited the vascular and airway responses. Adding MP to the perfusate of pretreated lungs further reduced the ROS-induced smooth muscle constriction. In conclusion, MP inhibits vasoconstriction and bronchoconstriction induced by ROS in isolated rat lungs.
Department of Anesthesiology, University of Tromsø, Norway.
J
J
Kjaeve
T
T
Ingebrigtsen
L
L
Naess
L
L
Bjertnaes
J
J
Vaage
D000818:Animals; D001794:Blood Pressure; D016084:Bronchoconstriction / Q000187:drug effects*; D019271:Hypoxanthine / Q000494:pharmacology; D007700:Kinetics; D008168:Lung / Q000098:blood supply* / Q000187:drug effects*; D008297:Male; D008775:Methylprednisolone / Q000494:pharmacology*; D010477:Perfusion; D051381:Rats; D017208:Rats, Wistar; D017382:Reactive Oxygen Species; D012128:Respiratory Distress Syndrome / Q000209:etiology; D014661:Vasoconstriction / Q000187:drug effects*; D014969:Xanthine Oxidase / Q000494:pharmacology
D017382:Reactive Oxygen Species; D019271:Hypoxanthine; D014969:Xanthine Oxidase; D008775:Methylprednisolone